None listed
Conditions
Brief summary
This pilot randomized controlled trial evaluates whether self-paced e-learning modules, delivered via Canvas Catalog, improve the decision-making abilities of healthcare professionals in the management of Type 2 Diabetes using smart technologies. Participants will be randomly assigned to one of two groups: an intervention group, which will complete interactive modules and a virtual simulation exam, or a control group, which will receive standard online diabetes education over a three-week period. The primary outcome is to assess the Impact of an educational e-Learning module for T2D smart technology on diabetes care. Secondary outcomes include self-reported enablers and barriers, levels of confidence, and engagement.
Interventions
The e-Learning modules were developed by a multidisciplinary team, including diabetes endocrinologists, diabetes educators, pharmacologists, podiatrists, and nurses. The modules provide comprehensive education on the management of Type 2 Diabetes (T2D) using digital technology, with a focus on interpreting the Ambulatory Glucose Profile (AGP).
Participants will complete three sequential modules over three weeks:
- Module 1: Introduction and understanding of the AGP
- Module 2: Interpretation of
The e-Learning modules were developed by a multidisciplinary team, including diabetes endocrinologists, diabetes educators, pharmacologists, podiatrists, and nurses. The modules provide comprehensive education on the management of Type 2 Diabetes (T2D) using digital technology, with a focus on interpreting the Ambulatory Glucose Profile (AGP). Participants will complete three sequential modules over three weeks: - Module 1: Introduction and understanding of the AGP - Module 2: Interpretation of Time in Range - Module 3: Practical application of the AGP in clinical practice Module Presentation and Interactivity: - Each module includes short instructional videos, interactive activities, and knowledge-check quizzes at the end of sections to reinforce learning. - Modules are hosted on the Canvas Catalog platform, with participants progressing sequentially (Module 1, Module 2, and Module 3). Completion of each module unlocks the next. - Participants may review previously completed modules at any time. - Comprehensive resources pages accompany each module, containing hyperlinks to academic papers, guidelines (e.g., ADA, International Consensus on Time in Range, ADS), and educational videos to reinforce learning. Engagement and Support: - Weekly announcements and personalized notifications on Canvas remind participants to access modules, complete assessments, and stay engaged. - Participant activity and completion are monitored through Canvas analytics, including module completion rates, attendance, and overall engagement. This structure ensures that participants not only acquire knowledge and decision-making skills but also remain actively engaged through a combination of videos, interactive exercises, quizzes, and supplementary resources.
Sponsors
the University of Newcastle
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used)
Eligibility
Sex/Gender
All
Healthy volunteers
Yes
Inclusion criteria
• Participant must be registered GP, AHP (such as diabetes educators), and RNs. • Treating and/or managing patients with T2DM. • Participants must be registered with the Australian Health Professionals Regulatory Agency in order to be considered for eligibility. • Access to a desktop, laptop computer or tablet with an internet connection.
Exclusion criteria
•Having completed digital technology training in T2D in the last 2 years. • Unwilling to use a PC / tablet in order to complete the online training. • Unwilling to complete the survey or 2hr virtual examination. • Currently engaged in another research project (to prevent concurrent participation in multiple studies, minimising the potential for interference that may compromise the integrity of the results). • Participants who include in feasibility and acceptability study will be exclude from Pilot RCT phase.
Outcome results
None listed